Literature DB >> 33216376

Motion sensor-acquired reachable workspace correlates with patient-reported upper extremity activities of daily living (ADL) function in facioscapulohumeral dystrophy.

Maya N Hatch1, Gregorij Kurillo2, Vicky Chan1, Jay J Han1.   

Abstract

BACKGROUND: This study examines the correlation, and clinical meaningfulness, between reachable workspace outcome and reported activities of daily living (ADL) function of individuals with facioscapulohumeral dystrophy (FSHD).
METHODS: Twenty-one FSHD subjects with various disease severity (clinical severity scores 1-4) underwent reachable workspace evaluation and completed the Quality of Life in Neurological Disorders (NeuroQoL) upper extremity questionnaire. Spearman and receiver operator curve analyses were performed.
RESULTS: Moderate correlation was found between NeuroQoL scores and total (ρ = 0.7609; P < .01), and upper-quadrants relative surface areas (RSAs) (ρ = 0.6969; P < .01). Five specific items (ie, shirt on, shirt off, use spoon, pull on pants, pick-up clothes) demonstrated even higher correlations with total (ρ = 0.8397; P < .01) and above shoulder (ρ = 0.8082; P < .01) RSAs. A total RSA cuffoff value of 0.70 would achieve 100% sensitivity and 94% specificity (area under the curve = 0.975).
CONCLUSIONS: Reachable workspace values identify when individuals have difficulties performing ADLs at home. This information improves patient monitoring, and clinical decision making by enabling more timely recommendations for medications, assistive devices, or considerations for clinical trial enrollments.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  activities of daily living; correlation; muscular dystrophy; outcome assessment; physical function

Mesh:

Year:  2020        PMID: 33216376      PMCID: PMC9526448          DOI: 10.1002/mus.27123

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.852


  19 in total

1.  A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.

Authors: 
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

2.  A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score.

Authors:  Costanza Lamperti; Greta Fabbri; Liliana Vercelli; Roberto D'Amico; Roberto Frusciante; Emanuela Bonifazi; Chiara Fiorillo; Carlo Borsato; Michelangelo Cao; Maura Servida; Francesca Greco; Rita Di Leo; Leda Volpi; Claudia Manzoli; Paola Cudia; Ebe Pastorello; Leopoldo Ricciardi; Gabriele Siciliano; Giuliana Galluzzi; Carmelo Rodolico; Lucio Santoro; Giuliano Tomelleri; Corrado Angelini; Enzo Ricci; Laura Palmucci; Maurizio Moggio; Rossella Tupler
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

3.  Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Authors:  K E Personius; S Pandya; W M King; R Tawil; M P McDermott
Journal:  Phys Ther       Date:  1994-03

4.  Longitudinal study of upper extremity reachable workspace in fascioscapulohumeral muscular dystrophy.

Authors:  Maya N Hatch; Kiin Kim; Gregorij Kurillo; Alina Nicorici; Craig M McDonald; Jay J Han
Journal:  Neuromuscul Disord       Date:  2019-05-23       Impact factor: 4.296

5.  Performance measures predict onset of activity of daily living difficulty in community-dwelling older adults.

Authors:  Wen-Ni Wennie Huang; Subashan Perera; Jessie VanSwearingen; Stephanie Studenski
Journal:  J Am Geriatr Soc       Date:  2010-04-14       Impact factor: 5.562

6.  Berg balance scale and outcome measures in acquired brain injury.

Authors:  J A Feld; M H Rabadi; A D Blau; B D Jordan
Journal:  Neurorehabil Neural Repair       Date:  2001       Impact factor: 3.919

7.  Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy.

Authors:  D D Kilmer; R T Abresch; M A McCrory; G T Carter; W M Fowler; E R Johnson; C M McDonald
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

8.  Reachable workspace in facioscapulohumeral muscular dystrophy (FSHD) by Kinect.

Authors:  Jay J Han; Gregorij Kurillo; Richard T Abresch; Evan de Bie; Alina Nicorici; Ruzena Bajcsy
Journal:  Muscle Nerve       Date:  2014-11-19       Impact factor: 3.217

9.  Measures of physical functioning predict self-reported performance in self-care, mobility, and domestic life in ambulatory persons with multiple sclerosis.

Authors:  Jaana Paltamaa; Taneli Sarasoja; Esko Leskinen; Juhani Wikström; Esko Mälkiä
Journal:  Arch Phys Med Rehabil       Date:  2007-12       Impact factor: 3.966

10.  The timed "Up & Go": a test of basic functional mobility for frail elderly persons.

Authors:  D Podsiadlo; S Richardson
Journal:  J Am Geriatr Soc       Date:  1991-02       Impact factor: 5.562

View more
  3 in total

Review 1.  Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.

Authors:  Mehdi Ghasemi; Charles P Emerson; Lawrence J Hayward
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

2.  Reachable workspace analysis is a potential measurement for impairment of the upper extremity in neuralgic amyotrophy.

Authors:  Jos IJspeert; Renee Lustenhouwer; Renske M Janssen; Jay J Han; Maya N Hatch; Ian Cameron; Rick C Helmich; Baziel van Engelen; Philip van der Wees; Alexander C H Geurts; Nens van Alfen; Jan T Groothuis
Journal:  Muscle Nerve       Date:  2022-06-21       Impact factor: 3.852

Review 3.  Current Trends and Challenges in Pediatric Access to Sensorless and Sensor-Based Upper Limb Exoskeletons.

Authors:  Guillaume Gaudet; Maxime Raison; Sofiane Achiche
Journal:  Sensors (Basel)       Date:  2021-05-20       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.